Crossmark

Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes

Crossref DOI link: https://doi.org/10.1016/j.farma.2025.02.010

Published Print: 2025-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

García-Díaz, Héctor Carlos

Larrosa-Garcia, María

Gómez-Alonso, Javier

Cruellas, Mara

Felip, Enriqueta

Macarulla, Teresa

Farriols, Anna

Carreras, Maria J.
License Information

Text and Data Mining valid from 2025-09-01

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-02-26
More Information

This article is maintained by: Elsevier

Article Title: Off-label use of olaparib in uncommon tumor locations in patients with impaired homologous recombination genes

Journal Title: Farmacia Hospitalaria

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.farma.2025.02.010

Content Type: article

Copyright: © 2025 The Author(s). Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Farmacia Hospitalaria (S.E.F.H).